These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24522498)

  • 1. Robust methods to improve efficiency and reduce bias in estimating survival curves in randomized clinical trials.
    Zhang M
    Lifetime Data Anal; 2015 Jan; 21(1):119-37. PubMed ID: 24522498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressing estimators of expected quality adjusted survival as functions of Nelson-Aalen estimators.
    Huang Y; Louis TA
    Lifetime Data Anal; 1999 Sep; 5(3):199-212. PubMed ID: 10518370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A flexible semiparametric transformation model for recurrent event data.
    Dong L; Sun L
    Lifetime Data Anal; 2015 Jan; 21(1):20-41. PubMed ID: 24241908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.
    Díaz I; van der Laan MJ
    Stat Med; 2017 Oct; 36(24):3807-3819. PubMed ID: 28744883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining biomarkers for classification with covariate adjustment.
    Kim S; Huang Y
    Stat Med; 2017 Jul; 36(15):2347-2362. PubMed ID: 28276080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.
    Lueza B; Rotolo F; Bonastre J; Pignon JP; Michiels S
    BMC Med Res Methodol; 2016 Mar; 16():37. PubMed ID: 27025706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.
    Zhao Y; Saville BR; Zhou H; Koch GG
    J Biopharm Stat; 2016; 26(2):269-79. PubMed ID: 25635808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survivor model with bivariate random effects: applications to bone marrow transplant and carcinoma study data.
    Lai X; Yau KK
    Stat Med; 2008 Nov; 27(27):5692-708. PubMed ID: 18712761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjusting for observational secondary treatments in estimating the effects of randomized treatments.
    Zhang M; Wang Y
    Biostatistics; 2013 Jul; 14(3):491-501. PubMed ID: 23349243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim analysis of binary outcome data in clinical trials: a comparison of five estimators.
    Lu QS; Chow SC; Tse SK
    J Biopharm Stat; 2019; 29(2):400-410. PubMed ID: 30599798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials.
    Yuan S; Zhang HH; Davidian M
    Stat Med; 2012 Dec; 31(29):3789-804. PubMed ID: 22733628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 May; 9(2):307-38. PubMed ID: 10379696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach.
    Tsiatis AA; Davidian M; Zhang M; Lu X
    Stat Med; 2008 Oct; 27(23):4658-77. PubMed ID: 17960577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies.
    Wang X; Bai F; Pang H; George SL
    J Biopharm Stat; 2019; 29(4):592-605. PubMed ID: 31286838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving efficiency in clinical trials using auxiliary information: Application of a multi-state cure model.
    Conlon AS; Taylor JM; Sargent DJ
    Biometrics; 2015 Jun; 71(2):460-8. PubMed ID: 25585942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced precision in the analysis of randomized trials with ordinal outcomes.
    Díaz I; Colantuoni E; Rosenblum M
    Biometrics; 2016 Jun; 72(2):422-31. PubMed ID: 26576013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of a decreasing hazard of patients with acute coronary syndrome.
    van Geloven N; Martin I; Damman P; de Winter RJ; Tijssen JG; Lopuhaä HP
    Stat Med; 2013 Mar; 32(7):1223-38. PubMed ID: 22829475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landmark estimation of survival and treatment effects in observational studies.
    Parast L; Griffin BA
    Lifetime Data Anal; 2017 Apr; 23(2):161-182. PubMed ID: 26880366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.